Current Cancer Drug Targets


Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 5 Issue: 4, June

Antiangiogenic Therapy in Acute Myelogenous Leukemia: Targeting of Vascular Endothelial Growth Factor and Interleukin 8 as Possible Antileukemic Strategies

Volume:5   Issue: 4
Pp: 229-248
Kimberley J. Hatfield, Astrid M. Olsnes, Bjorn Tore Gjertsen and Oystein Bruserud
DOI: 10.2174/1568009054064651
Published on: 01 March, 2012

Squalamine: A Polyvalent Drug of the Future?

Volume:5   Issue: 4
Pp: 267-272
Jean Michel Brunel, Chanaz Salmi, Celine Loncle, Nicolas Vidal and Yves Letourneux
DOI: 10.2174/1568009054064642
Published on: 01 March, 2012

The MYCN Oncogene as a Specific and Selective Drug Target for Peripheral and Central Nervous System Tumors

Volume:5   Issue: 4
Pp: 273-283
Andrea Pession and Roberto Tonelli
DOI: 10.2174/1568009054064606
Published on: 01 March, 2012

Matrix Metalloproteinase Inhibitors as Anticancer Therapeutics

Volume:5   Issue: 4
Pp: 285-298
F. Mannello, G. Tonti and S. Papa
DOI: 10.2174/1568009054064615
Published on: 01 March, 2012

The Anti-Tumor Effect and Mechanisms of Action of Penta-Acetyl Geniposide

Volume:5   Issue: 4
Pp: 299-305
C. H. Peng, C. N. Huang and C. J. Wang
DOI: 10.2174/1568009054064633
Published on: 01 March, 2012